EcoDrugPlus

Platelet Activating Factor Receptor

Ensembl ID : ENSONIG00000005054
Gene Symbol: PTAFR
1 Cross references
210 Possible Orthologues:

Platelet Activating Factor Receptor

Ensembl ID : ENSONIG00000005055
Gene Symbol: PTAFR
1 Cross references
208 Possible Orthologues:

Platelet Activating Factor Receptor

Ensembl ID : ENSONIG00000029766
Gene Symbol: PTAFR
1 Cross references
212 Possible Orthologues:

Platelet Derived Growth Factor Receptor Alpha

Ensembl ID : ENSONIG00000003001
Gene Symbol: PDGFRA
3 Cross references
203 Possible Orthologues:

Platelet Derived Growth Factor Receptor Beta

Ensembl ID : ENSONIG00000013070
Gene Symbol: PDGFRB
3 Cross references
198 Possible Orthologues:

Platelet-Derived Growth Factor Receptor Beta

Ensembl ID : ENSONIG00000017780
Gene Symbol: LOC100709470
2 Cross references
174 Possible Orthologues:

Polo Like Kinase 4

Ensembl ID : ENSONIG00000020136
Gene Symbol: PLK4
4 Cross references
215 Possible Orthologues:

Poly (Adp-Ribose) Polymerase 2

Ensembl ID : ENSONIG00000015194
Gene Symbol: PARP2
1 Cross references
185 Possible Orthologues:

Poly (Adp-Ribose) Polymerase Family, Member 3

Ensembl ID : ENSONIG00000018986
Gene Symbol: PARP3
1 Cross references
197 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 1

Ensembl ID : ENSONIG00000013486
Gene Symbol: PARP1
4 Cross references
209 Possible Orthologues:

Porcupine O-Acyltransferase

Ensembl ID : ENSONIG00000016858
Gene Symbol: PORCN
4 Cross references
193 Possible Orthologues:

Porcupine O-Acyltransferase

Ensembl ID : ENSONIG00000011643
Gene Symbol: PORCN
4 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).